Global Gastrointestinal Cancer Drugs Supply, Demand and Key Producers, 2023-2029

Description

Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems.

This report studies the global Gastrointestinal Cancer Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Gastrointestinal Cancer Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gastrointestinal Cancer Drugs that contribute to its increasing demand across many markets.

The global Gastrointestinal Cancer Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Highlights and key features of the study
Global Gastrointestinal Cancer Drugs total production and demand, 2018-2029, (g)
Global Gastrointestinal Cancer Drugs total production value, 2018-2029, (USD Million)
Global Gastrointestinal Cancer Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (g)
Global Gastrointestinal Cancer Drugs consumption by region & country, CAGR, 2018-2029 & (g)
U.S. VS China: Gastrointestinal Cancer Drugs domestic production, consumption, key domestic manufacturers and share
Global Gastrointestinal Cancer Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (g)
Global Gastrointestinal Cancer Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (g)
Global Gastrointestinal Cancer Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (g)
This reports profiles key players in the global Gastrointestinal Cancer Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen & Amgen Ireland, Bristol-Myers Squibb Company, Roche, Eli Lilly and Company, Johnson & Johnson Private, GlaxoSmithKline, Celgene Corporation, Pfizer and Sanofi, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gastrointestinal Cancer Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (g) and average price (USD/g) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Gastrointestinal Cancer Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Gastrointestinal Cancer Drugs Market, Segmentation by Type
    Oncology
    Radiology
    Others

Global Gastrointestinal Cancer Drugs Market, Segmentation by Application
    Hospitals
    Specialized Cancer Treatment Centers
    Clinics
    Ambulatory Surgical Centers

Companies Profiled:
    Amgen & Amgen Ireland
    Bristol-Myers Squibb Company
    Roche
    Eli Lilly and Company
    Johnson & Johnson Private
    GlaxoSmithKline
    Celgene Corporation
    Pfizer
    Sanofi
    Novartis

Key Questions Answered
1. How big is the global Gastrointestinal Cancer Drugs market?
2. What is the demand of the global Gastrointestinal Cancer Drugs market?
3. What is the year over year growth of the global Gastrointestinal Cancer Drugs market?
4. What is the production and production value of the global Gastrointestinal Cancer Drugs market?
5. Who are the key producers in the global Gastrointestinal Cancer Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Gastrointestinal Cancer Drugs Introduction
    1.2 World Gastrointestinal Cancer Drugs Supply & Forecast
        1.2.1 World Gastrointestinal Cancer Drugs Production Value (2018 & 2022 & 2029)
        1.2.2 World Gastrointestinal Cancer Drugs Production (2018-2029)
        1.2.3 World Gastrointestinal Cancer Drugs Pricing Trends (2018-2029)
    1.3 World Gastrointestinal Cancer Drugs Production by Region (Based on Production Site)
        1.3.1 World Gastrointestinal Cancer Drugs Production Value by Region (2018-2029)
        1.3.2 World Gastrointestinal Cancer Drugs Production by Region (2018-2029)
        1.3.3 World Gastrointestinal Cancer Drugs Average Price by Region (2018-2029)
        1.3.4 North America Gastrointestinal Cancer Drugs Production (2018-2029)
        1.3.5 Europe Gastrointestinal Cancer Drugs Production (2018-2029)
        1.3.6 China Gastrointestinal Cancer Drugs Production (2018-2029)
        1.3.7 Japan Gastrointestinal Cancer Drugs Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Gastrointestinal Cancer Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Gastrointestinal Cancer Drugs Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Gastrointestinal Cancer Drugs Demand (2018-2029)
    2.2 World Gastrointestinal Cancer Drugs Consumption by Region
        2.2.1 World Gastrointestinal Cancer Drugs Consumption by Region (2018-2023)
        2.2.2 World Gastrointestinal Cancer Drugs Consumption Forecast by Region (2024-2029)
    2.3 United States Gastrointestinal Cancer Drugs Consumption (2018-2029)
    2.4 China Gastrointestinal Cancer Drugs Consumption (2018-2029)
    2.5 Europe Gastrointestinal Cancer Drugs Consumption (2018-2029)
    2.6 Japan Gastrointestinal Cancer Drugs Consumption (2018-2029)
    2.7 South Korea Gastrointestinal Cancer Drugs Consumption (2018-2029)
    2.8 ASEAN Gastrointestinal Cancer Drugs Consumption (2018-2029)
    2.9 India Gastrointestinal Cancer Drugs Consumption (2018-2029)

3 World Gastrointestinal Cancer Drugs Manufacturers Competitive Analysis
    3.1 World Gastrointestinal Cancer Drugs Production Value by Manufacturer (2018-2023)
    3.2 World Gastrointestinal Cancer Drugs Production by Manufacturer (2018-2023)
    3.3 World Gastrointestinal Cancer Drugs Average Price by Manufacturer (2018-2023)
    3.4 Gastrointestinal Cancer Drugs Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Gastrointestinal Cancer Drugs Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Gastrointestinal Cancer Drugs in 2022
        3.5.3 Global Concentration Ratios (CR8) for Gastrointestinal Cancer Drugs in 2022
    3.6 Gastrointestinal Cancer Drugs Market: Overall Company Footprint Analysis
        3.6.1 Gastrointestinal Cancer Drugs Market: Region Footprint
        3.6.2 Gastrointestinal Cancer Drugs Market: Company Product Type Footprint
        3.6.3 Gastrointestinal Cancer Drugs Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Gastrointestinal Cancer Drugs Production Value Comparison
        4.1.1 United States VS China: Gastrointestinal Cancer Drugs Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Gastrointestinal Cancer Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Gastrointestinal Cancer Drugs Production Comparison
        4.2.1 United States VS China: Gastrointestinal Cancer Drugs Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Gastrointestinal Cancer Drugs Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Gastrointestinal Cancer Drugs Consumption Comparison
        4.3.1 United States VS China: Gastrointestinal Cancer Drugs Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Gastrointestinal Cancer Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Gastrointestinal Cancer Drugs Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Gastrointestinal Cancer Drugs Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Gastrointestinal Cancer Drugs Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Gastrointestinal Cancer Drugs Production (2018-2023)
    4.5 China Based Gastrointestinal Cancer Drugs Manufacturers and Market Share
        4.5.1 China Based Gastrointestinal Cancer Drugs Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Gastrointestinal Cancer Drugs Production Value (2018-2023)
        4.5.3 China Based Manufacturers Gastrointestinal Cancer Drugs Production (2018-2023)
    4.6 Rest of World Based Gastrointestinal Cancer Drugs Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Gastrointestinal Cancer Drugs Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Gastrointestinal Cancer Drugs Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Gastrointestinal Cancer Drugs Production (2018-2023)

5 Market Analysis by Type
    5.1 World Gastrointestinal Cancer Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Oncology
        5.2.2 Radiology
        5.2.3 Others
    5.3 Market Segment by Type
        5.3.1 World Gastrointestinal Cancer Drugs Production by Type (2018-2029)
        5.3.2 World Gastrointestinal Cancer Drugs Production Value by Type (2018-2029)
        5.3.3 World Gastrointestinal Cancer Drugs Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Gastrointestinal Cancer Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospitals
        6.2.2 Specialized Cancer Treatment Centers
        6.2.3 Clinics
        6.2.4 Ambulatory Surgical Centers
    6.3 Market Segment by Application
        6.3.1 World Gastrointestinal Cancer Drugs Production by Application (2018-2029)
        6.3.2 World Gastrointestinal Cancer Drugs Production Value by Application (2018-2029)
        6.3.3 World Gastrointestinal Cancer Drugs Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Amgen & Amgen Ireland
        7.1.1 Amgen & Amgen Ireland Details
        7.1.2 Amgen & Amgen Ireland Major Business
        7.1.3 Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Product and Services
        7.1.4 Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Amgen & Amgen Ireland Recent Developments/Updates
        7.1.6 Amgen & Amgen Ireland Competitive Strengths & Weaknesses
    7.2 Bristol-Myers Squibb Company
        7.2.1 Bristol-Myers Squibb Company Details
        7.2.2 Bristol-Myers Squibb Company Major Business
        7.2.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Product and Services
        7.2.4 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Bristol-Myers Squibb Company Recent Developments/Updates
        7.2.6 Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
    7.3 Roche
        7.3.1 Roche Details
        7.3.2 Roche Major Business
        7.3.3 Roche Gastrointestinal Cancer Drugs Product and Services
        7.3.4 Roche Gastrointestinal Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Roche Recent Developments/Updates
        7.3.6 Roche Competitive Strengths & Weaknesses
    7.4 Eli Lilly and Company
        7.4.1 Eli Lilly and Company Details
        7.4.2 Eli Lilly and Company Major Business
        7.4.3 Eli Lilly and Company Gastrointestinal Cancer Drugs Product and Services
        7.4.4 Eli Lilly and Company Gastrointestinal Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Eli Lilly and Company Recent Developments/Updates
        7.4.6 Eli Lilly and Company Competitive Strengths & Weaknesses
    7.5 Johnson & Johnson Private
        7.5.1 Johnson & Johnson Private Details
        7.5.2 Johnson & Johnson Private Major Business
        7.5.3 Johnson & Johnson Private Gastrointestinal Cancer Drugs Product and Services
        7.5.4 Johnson & Johnson Private Gastrointestinal Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Johnson & Johnson Private Recent Developments/Updates
        7.5.6 Johnson & Johnson Private Competitive Strengths & Weaknesses
    7.6 GlaxoSmithKline
        7.6.1 GlaxoSmithKline Details
        7.6.2 GlaxoSmithKline Major Business
        7.6.3 GlaxoSmithKline Gastrointestinal Cancer Drugs Product and Services
        7.6.4 GlaxoSmithKline Gastrointestinal Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 GlaxoSmithKline Recent Developments/Updates
        7.6.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.7 Celgene Corporation
        7.7.1 Celgene Corporation Details
        7.7.2 Celgene Corporation Major Business
        7.7.3 Celgene Corporation Gastrointestinal Cancer Drugs Product and Services
        7.7.4 Celgene Corporation Gastrointestinal Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Celgene Corporation Recent Developments/Updates
        7.7.6 Celgene Corporation Competitive Strengths & Weaknesses
    7.8 Pfizer
        7.8.1 Pfizer Details
        7.8.2 Pfizer Major Business
        7.8.3 Pfizer Gastrointestinal Cancer Drugs Product and Services
        7.8.4 Pfizer Gastrointestinal Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Pfizer Recent Developments/Updates
        7.8.6 Pfizer Competitive Strengths & Weaknesses
    7.9 Sanofi
        7.9.1 Sanofi Details
        7.9.2 Sanofi Major Business
        7.9.3 Sanofi Gastrointestinal Cancer Drugs Product and Services
        7.9.4 Sanofi Gastrointestinal Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Sanofi Recent Developments/Updates
        7.9.6 Sanofi Competitive Strengths & Weaknesses
    7.10 Novartis
        7.10.1 Novartis Details
        7.10.2 Novartis Major Business
        7.10.3 Novartis Gastrointestinal Cancer Drugs Product and Services
        7.10.4 Novartis Gastrointestinal Cancer Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Novartis Recent Developments/Updates
        7.10.6 Novartis Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Gastrointestinal Cancer Drugs Industry Chain
    8.2 Gastrointestinal Cancer Drugs Upstream Analysis
        8.2.1 Gastrointestinal Cancer Drugs Core Raw Materials
        8.2.2 Main Manufacturers of Gastrointestinal Cancer Drugs Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Gastrointestinal Cancer Drugs Production Mode
    8.6 Gastrointestinal Cancer Drugs Procurement Model
    8.7 Gastrointestinal Cancer Drugs Industry Sales Model and Sales Channels
        8.7.1 Gastrointestinal Cancer Drugs Sales Model
        8.7.2 Gastrointestinal Cancer Drugs Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Gastrointestinal Cancer Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Gastrointestinal Cancer Drugs Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Gastrointestinal Cancer Drugs Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Gastrointestinal Cancer Drugs Production Value Market Share by Region (2018-2023)
    Table 5. World Gastrointestinal Cancer Drugs Production Value Market Share by Region (2024-2029)
    Table 6. World Gastrointestinal Cancer Drugs Production by Region (2018-2023) & (g)
    Table 7. World Gastrointestinal Cancer Drugs Production by Region (2024-2029) & (g)
    Table 8. World Gastrointestinal Cancer Drugs Production Market Share by Region (2018-2023)
    Table 9. World Gastrointestinal Cancer Drugs Production Market Share by Region (2024-2029)
    Table 10. World Gastrointestinal Cancer Drugs Average Price by Region (2018-2023) & (USD/g)
    Table 11. World Gastrointestinal Cancer Drugs Average Price by Region (2024-2029) & (USD/g)
    Table 12. Gastrointestinal Cancer Drugs Major Market Trends
    Table 13. World Gastrointestinal Cancer Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (g)
    Table 14. World Gastrointestinal Cancer Drugs Consumption by Region (2018-2023) & (g)
    Table 15. World Gastrointestinal Cancer Drugs Consumption Forecast by Region (2024-2029) & (g)
    Table 16. World Gastrointestinal Cancer Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Gastrointestinal Cancer Drugs Producers in 2022
    Table 18. World Gastrointestinal Cancer Drugs Production by Manufacturer (2018-2023) & (g)
    Table 19. Production Market Share of Key Gastrointestinal Cancer Drugs Producers in 2022
    Table 20. World Gastrointestinal Cancer Drugs Average Price by Manufacturer (2018-2023) & (USD/g)
    Table 21. Global Gastrointestinal Cancer Drugs Company Evaluation Quadrant
    Table 22. World Gastrointestinal Cancer Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Gastrointestinal Cancer Drugs Production Site of Key Manufacturer
    Table 24. Gastrointestinal Cancer Drugs Market: Company Product Type Footprint
    Table 25. Gastrointestinal Cancer Drugs Market: Company Product Application Footprint
    Table 26. Gastrointestinal Cancer Drugs Competitive Factors
    Table 27. Gastrointestinal Cancer Drugs New Entrant and Capacity Expansion Plans
    Table 28. Gastrointestinal Cancer Drugs Mergers & Acquisitions Activity
    Table 29. United States VS China Gastrointestinal Cancer Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Gastrointestinal Cancer Drugs Production Comparison, (2018 & 2022 & 2029) & (g)
    Table 31. United States VS China Gastrointestinal Cancer Drugs Consumption Comparison, (2018 & 2022 & 2029) & (g)
    Table 32. United States Based Gastrointestinal Cancer Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Gastrointestinal Cancer Drugs Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Gastrointestinal Cancer Drugs Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Gastrointestinal Cancer Drugs Production (2018-2023) & (g)
    Table 36. United States Based Manufacturers Gastrointestinal Cancer Drugs Production Market Share (2018-2023)
    Table 37. China Based Gastrointestinal Cancer Drugs Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Gastrointestinal Cancer Drugs Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Gastrointestinal Cancer Drugs Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Gastrointestinal Cancer Drugs Production (2018-2023) & (g)
    Table 41. China Based Manufacturers Gastrointestinal Cancer Drugs Production Market Share (2018-2023)
    Table 42. Rest of World Based Gastrointestinal Cancer Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Gastrointestinal Cancer Drugs Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Gastrointestinal Cancer Drugs Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Gastrointestinal Cancer Drugs Production (2018-2023) & (g)
    Table 46. Rest of World Based Manufacturers Gastrointestinal Cancer Drugs Production Market Share (2018-2023)
    Table 47. World Gastrointestinal Cancer Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Gastrointestinal Cancer Drugs Production by Type (2018-2023) & (g)
    Table 49. World Gastrointestinal Cancer Drugs Production by Type (2024-2029) & (g)
    Table 50. World Gastrointestinal Cancer Drugs Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Gastrointestinal Cancer Drugs Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Gastrointestinal Cancer Drugs Average Price by Type (2018-2023) & (USD/g)
    Table 53. World Gastrointestinal Cancer Drugs Average Price by Type (2024-2029) & (USD/g)
    Table 54. World Gastrointestinal Cancer Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Gastrointestinal Cancer Drugs Production by Application (2018-2023) & (g)
    Table 56. World Gastrointestinal Cancer Drugs Production by Application (2024-2029) & (g)
    Table 57. World Gastrointestinal Cancer Drugs Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Gastrointestinal Cancer Drugs Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Gastrointestinal Cancer Drugs Average Price by Application (2018-2023) & (USD/g)
    Table 60. World Gastrointestinal Cancer Drugs Average Price by Application (2024-2029) & (USD/g)
    Table 61. Amgen & Amgen Ireland Basic Information, Manufacturing Base and Competitors
    Table 62. Amgen & Amgen Ireland Major Business
    Table 63. Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Product and Services
    Table 64. Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Production (g), Price (USD/g), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Amgen & Amgen Ireland Recent Developments/Updates
    Table 66. Amgen & Amgen Ireland Competitive Strengths & Weaknesses
    Table 67. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
    Table 68. Bristol-Myers Squibb Company Major Business
    Table 69. Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Product and Services
    Table 70. Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Production (g), Price (USD/g), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Bristol-Myers Squibb Company Recent Developments/Updates
    Table 72. Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
    Table 73. Roche Basic Information, Manufacturing Base and Competitors
    Table 74. Roche Major Business
    Table 75. Roche Gastrointestinal Cancer Drugs Product and Services
    Table 76. Roche Gastrointestinal Cancer Drugs Production (g), Price (USD/g), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Roche Recent Developments/Updates
    Table 78. Roche Competitive Strengths & Weaknesses
    Table 79. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
    Table 80. Eli Lilly and Company Major Business
    Table 81. Eli Lilly and Company Gastrointestinal Cancer Drugs Product and Services
    Table 82. Eli Lilly and Company Gastrointestinal Cancer Drugs Production (g), Price (USD/g), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Eli Lilly and Company Recent Developments/Updates
    Table 84. Eli Lilly and Company Competitive Strengths & Weaknesses
    Table 85. Johnson & Johnson Private Basic Information, Manufacturing Base and Competitors
    Table 86. Johnson & Johnson Private Major Business
    Table 87. Johnson & Johnson Private Gastrointestinal Cancer Drugs Product and Services
    Table 88. Johnson & Johnson Private Gastrointestinal Cancer Drugs Production (g), Price (USD/g), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Johnson & Johnson Private Recent Developments/Updates
    Table 90. Johnson & Johnson Private Competitive Strengths & Weaknesses
    Table 91. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
    Table 92. GlaxoSmithKline Major Business
    Table 93. GlaxoSmithKline Gastrointestinal Cancer Drugs Product and Services
    Table 94. GlaxoSmithKline Gastrointestinal Cancer Drugs Production (g), Price (USD/g), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. GlaxoSmithKline Recent Developments/Updates
    Table 96. GlaxoSmithKline Competitive Strengths & Weaknesses
    Table 97. Celgene Corporation Basic Information, Manufacturing Base and Competitors
    Table 98. Celgene Corporation Major Business
    Table 99. Celgene Corporation Gastrointestinal Cancer Drugs Product and Services
    Table 100. Celgene Corporation Gastrointestinal Cancer Drugs Production (g), Price (USD/g), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Celgene Corporation Recent Developments/Updates
    Table 102. Celgene Corporation Competitive Strengths & Weaknesses
    Table 103. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 104. Pfizer Major Business
    Table 105. Pfizer Gastrointestinal Cancer Drugs Product and Services
    Table 106. Pfizer Gastrointestinal Cancer Drugs Production (g), Price (USD/g), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Pfizer Recent Developments/Updates
    Table 108. Pfizer Competitive Strengths & Weaknesses
    Table 109. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 110. Sanofi Major Business
    Table 111. Sanofi Gastrointestinal Cancer Drugs Product and Services
    Table 112. Sanofi Gastrointestinal Cancer Drugs Production (g), Price (USD/g), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Sanofi Recent Developments/Updates
    Table 114. Novartis Basic Information, Manufacturing Base and Competitors
    Table 115. Novartis Major Business
    Table 116. Novartis Gastrointestinal Cancer Drugs Product and Services
    Table 117. Novartis Gastrointestinal Cancer Drugs Production (g), Price (USD/g), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 118. Global Key Players of Gastrointestinal Cancer Drugs Upstream (Raw Materials)
    Table 119. Gastrointestinal Cancer Drugs Typical Customers
    Table 120. Gastrointestinal Cancer Drugs Typical Distributors
List of Figure
    Figure 1. Gastrointestinal Cancer Drugs Picture
    Figure 2. World Gastrointestinal Cancer Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Gastrointestinal Cancer Drugs Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Gastrointestinal Cancer Drugs Production (2018-2029) & (g)
    Figure 5. World Gastrointestinal Cancer Drugs Average Price (2018-2029) & (USD/g)
    Figure 6. World Gastrointestinal Cancer Drugs Production Value Market Share by Region (2018-2029)
    Figure 7. World Gastrointestinal Cancer Drugs Production Market Share by Region (2018-2029)
    Figure 8. North America Gastrointestinal Cancer Drugs Production (2018-2029) & (g)
    Figure 9. Europe Gastrointestinal Cancer Drugs Production (2018-2029) & (g)
    Figure 10. China Gastrointestinal Cancer Drugs Production (2018-2029) & (g)
    Figure 11. Japan Gastrointestinal Cancer Drugs Production (2018-2029) & (g)
    Figure 12. Gastrointestinal Cancer Drugs Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Gastrointestinal Cancer Drugs Consumption (2018-2029) & (g)
    Figure 15. World Gastrointestinal Cancer Drugs Consumption Market Share by Region (2018-2029)
    Figure 16. United States Gastrointestinal Cancer Drugs Consumption (2018-2029) & (g)
    Figure 17. China Gastrointestinal Cancer Drugs Consumption (2018-2029) & (g)
    Figure 18. Europe Gastrointestinal Cancer Drugs Consumption (2018-2029) & (g)
    Figure 19. Japan Gastrointestinal Cancer Drugs Consumption (2018-2029) & (g)
    Figure 20. South Korea Gastrointestinal Cancer Drugs Consumption (2018-2029) & (g)
    Figure 21. ASEAN Gastrointestinal Cancer Drugs Consumption (2018-2029) & (g)
    Figure 22. India Gastrointestinal Cancer Drugs Consumption (2018-2029) & (g)
    Figure 23. Producer Shipments of Gastrointestinal Cancer Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Gastrointestinal Cancer Drugs Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Gastrointestinal Cancer Drugs Markets in 2022
    Figure 26. United States VS China: Gastrointestinal Cancer Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Gastrointestinal Cancer Drugs Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Gastrointestinal Cancer Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Gastrointestinal Cancer Drugs Production Market Share 2022
    Figure 30. China Based Manufacturers Gastrointestinal Cancer Drugs Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Gastrointestinal Cancer Drugs Production Market Share 2022
    Figure 32. World Gastrointestinal Cancer Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Gastrointestinal Cancer Drugs Production Value Market Share by Type in 2022
    Figure 34. Oncology
    Figure 35. Radiology
    Figure 36. Others
    Figure 37. World Gastrointestinal Cancer Drugs Production Market Share by Type (2018-2029)
    Figure 38. World Gastrointestinal Cancer Drugs Production Value Market Share by Type (2018-2029)
    Figure 39. World Gastrointestinal Cancer Drugs Average Price by Type (2018-2029) & (USD/g)
    Figure 40. World Gastrointestinal Cancer Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 41. World Gastrointestinal Cancer Drugs Production Value Market Share by Application in 2022
    Figure 42. Hospitals
    Figure 43. Specialized Cancer Treatment Centers
    Figure 44. Clinics
    Figure 45. Ambulatory Surgical Centers
    Figure 46. World Gastrointestinal Cancer Drugs Production Market Share by Application (2018-2029)
    Figure 47. World Gastrointestinal Cancer Drugs Production Value Market Share by Application (2018-2029)
    Figure 48. World Gastrointestinal Cancer Drugs Average Price by Application (2018-2029) & (USD/g)
    Figure 49. Gastrointestinal Cancer Drugs Industry Chain
    Figure 50. Gastrointestinal Cancer Drugs Procurement Model
    Figure 51. Gastrointestinal Cancer Drugs Sales Model
    Figure 52. Gastrointestinal Cancer Drugs Sales Channels, Direct Sales, and Distribution
    Figure 53. Methodology
    Figure 54. Research Process and Data Source